Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of BM32, a Recombinant Hypoallergenic Grass Pollen Vaccine, by Skin Testing

NCT01350635 is registered in ClinicalTrials.gov with Biomay AG as lead sponsor.

NCT NCT01350635
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01350635 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of BM32, a Recombinant Hypoallergenic Grass Pollen Vaccine, by Skin Testing
Lead sponsor
Biomay AG
Phase
Phase 1/2
Overall status
Completed
Start date
May 31, 2011
Completion date
September 30, 2011
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypersensitivity